Induction of "Infectious" Tolerance to MHC-Incompatible Cardiac Allografts in CD4 Monoclonal Antibody-Treated Sensitized Rat Recipients

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 1944-1950

  Onodera, Kazuhiko ^a   Lehmann, Manfred ^c   Akalin, Enver ^b   Volk, Hans Dieter ^d   Sayegh, Mohamed H ^b   Kupiec Weglinski, Jerzy W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIIDIOTYPIC ANTIBODY; CD4 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RIB 5 2; MONOCLONAL ANTIBODY RIB 5-2;

ADOPTIVE TRANSFER; ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BIOSYNTHESIS; BROWN NORWAY RAT; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEWIS RAT; MALE; MIXED LYMPHOCYTE CULTURE; PASSIVE IMMUNIZATION; RAT; WISTAR FURTH RAT;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CYTOTOXICITY, IMMUNOLOGIC; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; RATS, INBRED WF; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030240965     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sanfilippo, F. P., W. K. Vaughn, T. G. Peters, C. F. Shield, P. L. Adams, M. I. Lorber, and G. M. Williams. 1992. Factors affecting the waiting time of cadaveric kidney transplant candidates in the United States. JAMA 267:247.
2. + cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 51:226.
3. Hancock, W. W., R. Di Stefano, P. Braun, R. Schweizer, N. L. Tilney, and J. W. Kupiec-Weglinski. 1990. CsA and anti-interleukin 2-receptor monoclonal antibody therapy in rats suppress accelerated rejection of cardiac allografts through different effector mechanisms. Transplantation 48:416.
4. Kupiec-Weglinski, J. W., T. Sablinski, W. W. Hancock, R. Di Stefano, G. Mariani, C. T. Mix, and N. L. Tilney. 1991. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy. Transplantation 51:300.
5. Shizuru, J. A., S. E. Alters, and C. G. Fathman. 1992. Anti-CD4 monoclonal antibodies in therapy: creation of non-classical tolerance in adults. Immunol. Rev. 129:105.
6. Binder, J., and J. W. Kupiec-Weglinski. 1993. CD4 targeted therapy in organ graft recipients. Transplant. Sci. 3:210.
7. Lehmann, M., F. Sternkopf, F. Metz, and H. D. Volk. 1992. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 54:959.
8. Siegling, A., M. Lehmann, H. Riedel, and H. D. Volk. 1994. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1 -like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 57:464.
9. Binder, J., M. Lehmann, E. Graser, W. W. Hancock, B. Watschinger, K. Onodera, M. H. Sayegh, H. D. Volk, and J. W. Kupiec-Weglinski. 1996. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 61:804.
10. Chen, Z., S. Cobbold, S. Metcalfe, and H. Waldmann. 1992. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, using monoclonal antibodies to CD4 and CD8. Eur. J. Immunol. 22:805.
11. Cobbold, S. P., S. Qin, L. Y. Leong, G. Martin, and H. Waldmann. 1992. Re-programming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol. Rev. 129:165.
12. Hutchings, P. R., A. Cooke, K. Dawe, H. Waldmann, and I. M. Roitt. 1992. Active suppression induced by anti-CD4. Eur. J. Immunol. 23:965.
13. Qin, S., S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" transplantation tolerance. Science 259:974.
14. Wieder, K. J., W. W. Hancock, G. Schmidbauer, C. L. Corpier, I. Wieder, L. Kobzik, T. B. Strom, and J. W. Kupiec-Weglinski. 1993. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-γ in rat recipients of cardiac allografts. J. Immunol. 151:1158.
15. Heidecke, C. D., W. W. Hancock, F. Jakobs, N. Zantl, R. Kurrle, S. Westerholt, T. Szewczik, K. Deusch, and J. W. Kupiec-Weglinski. 1995. α/β-T cell receptor-directed therapy in rat cardiac allograft recipients: treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection. Transplantation 59:78.
16. Yin, D., and C. G. Fathman. 1995. CD4-positive suppressor cells block allotransplant rejection. J. Immunol. 154:6339.
17. Yin, D., and C. G. Fathman. 1995. Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4Ig. J. Immunol. 155: 1655.
18. Kupiec-Weglinski, J. W., B. Wasowska, G. Schmidbauer, M. H. Sayegh, and W. W. Hancock. 1993. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J. Immunol. 151:5053.
19. Der Balian, G. P., J. Slack, B. L. Clevinger, H. Bazin, and J. M. Davie. 1980. Subclass restriction of murine antibodies. J. Exp. Med. 152:209.
20. Azuma, H., and N. L. Tilney. 1994. Chronic graft rejection. Curr. Opin. Immunol. 6:770.
21. Cobbold, S. P., A. Jayesuriya, T. D. Prospeno, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312: 548.
22. Wofsy, D., and W. E. Seaman. 1985. Successful treatment of autoimmunity in NZB/NZWF1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378.
23. Benjamin, R. J., S. P. Cobbold, M. R. Clark, and H. Waldmann. 1986. Tolerance to rat monoclonal antibodies: implications to serotherapy. J. Exp. Med. 163:1539.
24. + T cells in vivo: differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J. Immunol. 148:1308.
25. Takeuchi, T., R. P. Lowry, and B. Konieczny. 1992. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 53:1281.
26. Hancock, W. W., M. H. Sayegh, C. A. Kwok, H. L. Weiner, and C. B. Carpenter. 1993. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 55:1112.
27. + T cells in the presence of nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J. Exp. Med. 182:5.
28. lck. Nature 338:257.
29. lck. Nature 350:62.
30. Munoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95.